Literature DB >> 26618514

Sialylation of anti-histone immunoglobulin G autoantibodies determines their capabilities to participate in the clearance of late apoptotic cells.

I Magorivska1,2, L E Muñoz1, C Janko3, T Dumych2, J Rech1, G Schett1, F Nimmerjahn4, R Bilyy1,2, M Herrmann1.   

Abstract

The Fc portion of immunoglobulin (Ig)G harbours a single glycosylation site. Glycan sialylation is critical for structure and for certain effector functions of IgG. Anti-histone IgG of patients with systemic lupus erythematosus is reportedly responsible for the recruitment of polymorphonuclear cells (PMN) to the clearance of apoptotic cells. Autoantibodies decorating secondary necrotic cells (SNEC) induce proinflammatory responses after activation of blood-borne phagocytes. Analysing the sialylation status of affinity-purified anti-histone IgG in patients with systemic lupus erythematosus (SLE), we demonstrated that the anti-histone IgG was contained preferentially in the non-sialylated fraction. In functional ex-vivo phagocytosis studies, non-sialylated anti-SNEC IgG directed SNEC preferentially into PMN but did not change their cytokine secretion profiles. In contrast, sialylated IgG reduced the phagocytosis by monocytes of SNEC. Moreover, the sialylated anti-SNEC IgG was not simply anti-inflammatory, but switched the cytokine secretion profiles from interleukin (IL)-6/IL-8 to tumour necrosis factor (TNF)-α/IL-1β. Here we describe how different sialylation statuses of IgG autoantibodies contribute to the complex inflammatory network that regulates chronic inflammation.
© 2016 British Society for Immunology.

Entities:  

Keywords:  IgG; SLE; autoantibodies; lectin; sialylation

Mesh:

Substances:

Year:  2016        PMID: 26618514      PMCID: PMC4778101          DOI: 10.1111/cei.12744

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles.

Authors:  Rostyslav O Bilyy; Tanya Shkandina; Andriy Tomin; Luis E Muñoz; Sandra Franz; Volodymyr Antonyuk; Yuriy Ya Kit; Matthias Zirngibl; Barbara G Fürnrohr; Christina Janko; Kirsten Lauber; Martin Schiller; Georg Schett; Rostyslav S Stoika; Martin Herrmann
Journal:  J Biol Chem       Date:  2011-11-10       Impact factor: 5.157

2.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

Review 3.  The role of defective clearance of apoptotic cells in systemic autoimmunity.

Authors:  Luis E Muñoz; Kirsten Lauber; Martin Schiller; Angelo A Manfredi; Martin Herrmann
Journal:  Nat Rev Rheumatol       Date:  2010-05       Impact factor: 20.543

4.  IgG opsonized nuclear remnants from dead cells cause systemic inflammation in SLE.

Authors:  Luis E Munoz; Christina Janko; Ricardo A Chaurio; Georg Schett; Udo S Gaipl; Martin Herrmann
Journal:  Autoimmunity       Date:  2010-04       Impact factor: 2.815

5.  In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner.

Authors:  Heike Albert; Mattias Collin; Diana Dudziak; Jeffrey V Ravetch; Falk Nimmerjahn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-24       Impact factor: 11.205

Review 6.  Analytical and Functional Aspects of Antibody Sialylation.

Authors:  Johannes Stadlmann; Martin Pabst; Friedrich Altmann
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

7.  Exposure of chromatin and not high affinity for dsDNA determines the nephritogenic impact of anti-dsDNA antibodies in (NZBxNZW)F1 mice.

Authors:  Janne Erikke Mjelle; Manar Kalaaji; Ole Petter Rekvig
Journal:  Autoimmunity       Date:  2009-02       Impact factor: 2.815

8.  Loading of nuclear autoantigens prototypically recognized by systemic lupus erythematosus sera into late apoptotic vesicles requires intact microtubules and myosin light chain kinase activity.

Authors:  M Zirngibl; B G Fürnrohr; C Janko; L E Munoz; R E Voll; C D Gregory; G Schett; M Herrmann
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

9.  The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation.

Authors:  Christoph Fickentscher; Iryna Magorivska; Christina Janko; Mona Biermann; Rostyslav Bilyy; Cecilia Nalli; Angela Tincani; Veronica Medeghini; Antonella Meini; Falk Nimmerjahn; Georg Schett; Luis E Muñoz; Laura Andreoli; Martin Herrmann
Journal:  J Immunol Res       Date:  2015-06-22       Impact factor: 4.818

10.  Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis.

Authors:  Christopher Sjöwall; Agneta Zickert; Thomas Skogh; Jonas Wetterö; Iva Gunnarsson
Journal:  Arthritis Res Ther       Date:  2009-12-11       Impact factor: 5.156

View more
  8 in total

1.  The history of IgG glycosylation and where we are now.

Authors:  Brian A Cobb
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

2.  Glycosylation in Autoimmune Diseases.

Authors:  Marta Ząbczyńska; Paweł Link-Lenczowski; Ewa Pocheć
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

3.  Recombinant Proteins and Monoclonal Antibodies.

Authors:  Roy Jefferis
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

4.  Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis.

Authors:  Michael J Kemna; Rosina Plomp; Pieter van Paassen; Carolien A M Koeleman; Bas C Jansen; Jan G M C Damoiseaux; Jan Willem Cohen Tervaert; Manfred Wuhrer
Journal:  EBioMedicine       Date:  2017-01-28       Impact factor: 8.143

5.  Acquisition of N-Glycosylation Sites in Immunoglobulin Heavy Chain Genes During Local Expansion in Parotid Salivary Glands of Primary Sjögren Patients.

Authors:  Annie Visser; Marieke E Doorenspleet; Niek de Vries; Fred K L Spijkervet; Arjan Vissink; Richard J Bende; Hendrika Bootsma; Frans G M Kroese; Nicolaas A Bos
Journal:  Front Immunol       Date:  2018-03-12       Impact factor: 7.561

Review 6.  Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases.

Authors:  Danqi Li; Yuchen Lou; Yamin Zhang; Si Liu; Jun Li; Juan Tao
Journal:  Theranostics       Date:  2021-03-13       Impact factor: 11.556

7.  Liraglutide-Induced Hepatotoxicity.

Authors:  Yaakov Maor; David Ergaz; Stephen D H Malnick; Ehud Melzer; Manuela G Neuman
Journal:  Biomedicines       Date:  2021-01-22

Review 8.  Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases.

Authors:  Gillian Dekkers; Theo Rispens; Gestur Vidarsson
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.